TGTX — TG Therapeutics Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in TG Therapeutics Inc (TGTX), worth $40.59M combined. Over the quarter 3 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $37.32M | 0.05% | +99.3% |
| Navellier | $1.61M | 0.13% | NO CHANGE |
| Quadrature | $1.11M | 0.00% | +6.7% |
| VanEck | $431.61K | 0.00% | NEW |
| Pingora | $120.87K | 0.07% | -18.5% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.